The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biologically optimized schedule of gemcitabine and nab-paclitaxel regimen in metastatic pancreatic adenocarcinoma.
 
Laith I. Abushahin
Honoraria - Bionest Partner
Research Funding - Celgene (Inst)
 
Anne M. Noonan
Consulting or Advisory Role - Eisai; Exelixis; Helsinn Healthcare; QED Therapeutics
 
John L. Hays
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deciphera; Ipsen; Merck; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Merck; Tesaro
 
Pannaga G. Malalur
No Relationships to Disclose
 
Ashish Manne
No Relationships to Disclose
 
Ning Jin
No Relationships to Disclose
 
Arjun Mittra
No Relationships to Disclose
 
Rifat T. Elkhatib
No Relationships to Disclose
 
Sameek Roychowdhury
Stock and Other Ownership Interests - Johnson & Johnson (I)
Honoraria - Illumina; Integrated DNA Technologies
Consulting or Advisory Role - AbbVie; Incyte; Merck; QED Therapeutics
Research Funding - Ignyta; Incyte; QED Therapeutics; Takeda
 
Terence Marques Williams
Speakers' Bureau - MJH Healthcare Holdings, LLC
Research Funding - Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent pending on the development of novel chemotherapies based on work from my lab. The provisional application was submitted June 2018. However, we are abandoning our application.
Travel, Accommodations, Expenses - Varian Medical Systems